CSU logo TB Vaccine Testing and Research Materials Contract
Home
Vaccine Testing
Research Materials
  Materials Available
 
Links
Contacts
Frequently Asked Questions
Publications
BEI Resources Transition

Attention

Research materials produced by the TBVTRM Contract are distributed by the Biodefense and Emerging Infections Research Resources Repository (BEI Resources). Please visit our page on the BEI Resources website for complete ordering instructions:
http://www.beiresources.org/TBVTRMResearchMaterials/tabid/1431/Default.aspx .

Sulfolipid-1

Reagent:
Sulfolipid-1, SL-1

Default Quantity:
0.25 mg

Production system:
Sulfolipid-1 (SL-1) is first purified by extracting H37Rv Mtb cells with 2:1 chloroform/methanol and loading onto a silica gel column. The column is washed with chloroform, then eluted with 5% methanol in chloroform. This fraction, enriched in TDM and SL-1, is loaded onto C18 reverse phase SepPak filters and eluting with 60% chloroform in methanol to remove the TDM, then 25% to elute the SL-1.

Notes:
For most requests, this product will be made on demand due to yield and stability issues. Therefore, a delay should be anticipated.

Sulfolipid appears to be very labile. Dry storage at -80°C is recommended to prevent breakdown. As little as two days storage in solution at 4°C causes SL-I to become very non-polar, as evidenced by running on 2D-TLC.

 

Return to Lipids and Carbohydrates | Return to Materials Available